A patient with malignant lymphoma is administered the antineoplastic drug Rituximab 800 mg and then 100 mg of Benadryl. Which HCPCS Level II codes are reported for both drugs administered…

The correct answer is B. J9312, J1200. The patient with malignant lymphoma is administered Rituximab (800 mg) and Benadryl (100 mg) Procedure Description: Administration of Rituximab (800 mg) intravenously. Administration of Benadryl (100 mg) intravenously. HCPCS Level II Coding: J9312: Injection, Rituximab, 10 mg…

HCPCS Level II

Question

A patient with malignant lymphoma is administered the antineoplastic drug Rituximab 800 mg and then 100 mg of Benadryl. Which HCPCS Level II codes are reported for both drugs administered intravenously?

Options

AJ9312 x 80, J1200 x 2
BJ9312, J1200
CJ9312, Q0163
DJ9312 x 80, 00163 x 2

How the community answered

(29 responses)

A
3% (1)
B
83% (24)
C
10% (3)
D
3% (1)

Explanation

The patient with malignant lymphoma is administered Rituximab (800 mg) and Benadryl (100 mg) Procedure Description: Administration of Rituximab (800 mg) intravenously. Administration of Benadryl (100 mg) intravenously. HCPCS Level II Coding: J9312: Injection, Rituximab, 10 mg. For 800 mg, report 80 units of J9312. J1200: Injection, Diphenhydramine HCl, up to 50 mg. For 100 mg, report 2 units of J1200.

Topics

#Rituximab J-code#antineoplastic drug coding#Benadryl HCPCS#drug unit calculation

Community Discussion

No community discussion yet for this question.

Full CPC Practice